FERMENTA.BO BSE
Fermenta Biotech Ltd.
1W: +14.5%
1M: +14.1%
3M: +59.5%
YTD: +77.7%
1Y: +53.3%
3Y: +261.3%
5Y: +82.5%
₹557.20 ($5.79)
+5.85 (+1.06%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$6.1B
+12.2% ▲
5Y CAGR: -0.5%
Total Liabilities
$2.6B
-2.6% ▼
5Y CAGR: -4.3%
Shareholders Equity
$3.6B
+25.6% ▲
5Y CAGR: +3.2%
Cash & Investments
$707M
+18.1% ▲
5Y CAGR: +16.4%
Total Debt
$1.1B
-17.2% ▼
5Y CAGR: -12.5%
Net Debt
$867M
-25.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $271M | $210M | $353M | $218M | $282M |
| Short-Term Investments | $196M | $126M | $248M | $380M | $424M |
| Cash & ST Investments | $445M | $336M | $601M | $598M | $707M |
| Net Receivables | $854M | $951M | $467M | $787M | $1.1B |
| Inventory | $1.7B | $1.7B | $1.3B | $891M | $1.2B |
| Other Current Assets | $66M | $92M | $120M | $90M | $357M |
| Total Current Assets | $3.1B | $3.1B | $2.5B | $2.4B | $3.4B |
| Property, Plant & Equip. | $2.2B | $2.4B | $2.6B | $2.5B | $2.3B |
| Goodwill & Intangibles | $317M | $285M | $248M | $113M | $71M |
| Long-Term Investments | $692M | $733M | $4M | $4M | $41M |
| Other Non-Current Assets | $137M | $177M | $666M | $189M | $72M |
| Total Non-Current Assets | $3.8B | $3.9B | $3.8B | $3.1B | $2.8B |
| Total Assets | $7.1B | $7.1B | $6.4B | $5.5B | $6.1B |
| — Liabilities — | |||||
| Accounts Payable | $621M | $646M | $458M | $649M | $775M |
| Short-Term Debt | $1.2B | $1.2B | $1.3B | $897M | $944M |
| Deferred Revenue | $0 | $0 | $0 | $16M | $0 |
| Other Current Liabilities | $193M | $159M | $250M | $79M | $345M |
| Total Current Liabilities | $2.1B | $2.1B | $2.1B | $1.7B | $2.1B |
| Long-Term Debt | $1.1B | $1.1B | $836M | $425M | $150M |
| Other Non-Current Liab. | $50M | $114M | $0 | $229M | $244M |
| Total Non-Current Liabilities | $1.2B | $1.5B | $1.2B | $894M | $441M |
| Total Liabilities | $3.5B | $3.4B | $3.2B | $2.6B | $2.6B |
| — Equity — | |||||
| Common Stock | $144M | $144M | $144M | $144M | $146M |
| Retained Earnings | $3.2B | $3.3B | $2.8B | $2.9B | $3.3B |
| Accumulated OCI | $278M | $313M | $199M | -$183M | $56M |
| Total Stockholders Equity | $3.6B | $3.7B | $3.2B | $2.9B | $3.6B |
| Total Liabilities & Equity | $7.1B | $7.1B | $6.4B | $5.5B | $6.1B |
| — Key Metrics — | |||||
| Total Debt | $2.3B | $2.4B | $2.2B | $1.4B | $1.1B |
| Net Debt | $2.1B | $2.2B | $1.8B | $1.2B | $867M |
| Total Investments | $887M | $859M | $251M | $384M | $466M |